Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasoprotection and antihypertensive therapy

P D Henry1, O A Cabello

  • 1Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Current Opinion in Nephrology and Hypertension
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Green coffee polyphenols do not attenuate features of the metabolic syndrome and improve endothelial function in mice fed a high fat diet.

Archives of biochemistry and biophysics·2014
Same author

Cell cycle-dependent expression and nucleolar localization of hCAP-H.

Molecular biology of the cell·2001
Same author

Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids.

Circulation·2001
Same author

Chromosome condensation factor Brn1p is required for chromatid separation in mitosis.

Molecular biology of the cell·2000
Same author

Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression.

Circulation·2000
Same author

Shocks as predictors of survival in patients with implantable cardioverter-defibrillators.

Journal of the American College of Cardiology·1999

Vasoprotective drugs improve blood vessel health against hypertension and hypercholesterolemia. Some therapies benefit vessels even without normalizing blood pressure, addressing underlying vascular issues.

Area of Science:

  • Cardiovascular pharmacology
  • Vascular biology

Background:

  • Cardiovascular risk factors like hypertension and hypercholesterolemia increase blood vessel vulnerability.
  • Standard hypertension treatment may not resolve all associated vascular pathologies.
  • Endothelium-dependent vasodilation impairment is a key feature of hypertensive states.

Purpose of the Study:

  • To explore vasoprotective mechanisms beyond blood pressure normalization.
  • To evaluate the impact of specific therapies on vascular health in cardiovascular risk states.
  • To understand how estrogen, ACE inhibitors, and nitric oxide metabolism affect vascular function.

Main Methods:

  • Review of studies on estrogen replacement therapy.
  • Analysis of angiotensin-converting enzyme (ACE) inhibitors' effects.

Related Experiment Videos

  • Investigation of nitric oxide (NO) metabolism manipulations.
  • Assessment of endothelium-dependent vasodilation.
  • Evaluation of protection against hypercholesterolemia's atherogenic effects.

    • Main Results:

    • Estrogen and L-arginine can improve impaired endothelium-dependent vasodilation.
    • ACE inhibitors preserve endothelium-dependent vasodilation.
    • ACE inhibitors offer protection against hypercholesterolemia-induced arterial damage through non-hypotensive, non-hypolipidemic pathways.
    • Beneficial vascular effects observed independent of blood pressure normalization.

    Conclusions:

    • Therapies targeting nitric oxide metabolism and ACE inhibition offer vasoprotection.
    • These treatments can improve vascular function and reduce atherosclerosis risk.
    • Vascular benefits may be achieved without solely relying on blood pressure reduction.